Biogut Technologies Inc. is a subsiduary of Summa Bio-Solutions Inc.
Who We Are
Biogut Technologies Inc. is a Texas corporation with offices in the USA and Australia, and laboratories and contract laboratories in USA, Australia, and Greece. The company is led by pioneers in innovation of gastrointestinal health, infectious disease and cancer products and services, supported by a seasoned pharma management team and respected scientific research team.
As a result of many years of research and development, the Company’s science team has discovered novel diagnostics and therapeutics for inflammatory bowel disease, cancer, infectious disease, and fibrosis. The research work performed by the team members can be seen on the library page (publication library).
“All disease begins in the gut”
– Hippocrates, 430-375 A.D.
At Biogut, we are at the forefront of groundbreaking research and development, exploring the intricate connections between microbial metabolites and their receptors, the microbiome, and human health.
Our mission is to unlock the potential of microbial metabolites and their receptors to revolutionize diagnostics and therapeutics for a wide range of conditions, including cancer and fibrosis-related disorders.
With an unwavering commitment to innovation and scientific excellence, our multidisciplinary team of experts is dedicated to deciphering the complex interplay between microbiota and host physiology. Through cutting-edge technologies and rigorous research methodologies, we aim to uncover novel insights into the role of microbial metabolites in modulating myofibroblast function and cancer progression.
We leverage our deep understanding of microbiome dynamics to develop precision diagnostics that provide personalized insights into an individual’s health status. Additionally, our innovative therapeutics target specific microbial pathways to restore microbial homeostasis and mitigate disease progression.
Join us on our journey to harness the power of microbial metabolites for transformative healthcare solutions, as we strive to improve lives and advance the frontier of biomedicine.
-
Dr. Vasilis Paspaliaris
DIRECTOR & CHAIRMAN
-
Dr. Steve Brown
DIRECTOR & PRESIDENT
-
Peter Milonas
DIRECTOR & CHIEF MARKETING OFFICER
-
Prof. George Kolios
CHIEF MEDICAL & SCIENCE OFFICER
-
David Strawn
DIRECTOR OF LEGAL & COMPLIANCE
-
Dr. Donald Anderson
CHIEF EXECUTIVE OFFICER
-
Craig Peppin
CORPORATE ADVISOR
-
Dr. Mike Hutchinson
VETERINARY MEDICINE ADVISOR
-
Dr. Nikolas Dovrolis
CHIEF BIOINFORMATICS OFFICER